EyePoint Pharmaceuticals, Inc. (EYPT) PT Lowered to $4 at B.Riley/FBR
Tweet
Share
E-mailGet Alerts EYPT Hot Sheet
Price: $14.75 +9.42%
Rating Summary:
16 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
16 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
B.Riley/FBR analyst Andrew D\'Silva lowered the price target on EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) to $4.00 (from $5.75) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Calian Group Ltd (CGY:CN) (CLNFF) PT Raised to Cdn$109 at Desjardins
- Va Tech Wabag Ltd. (VATW:IN) PT Raised to INR2,410 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
